Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAbbott Laboratories Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 16 | $1.13 | $1.17 | $1.14 |
| Q2 2026 | 14 | $1.27 | $1.30 | $1.28 |
| Q3 2026 | 15 | $1.41 | $1.45 | $1.42 |
| Q4 2026 | 14 | $1.61 | $1.65 | $1.64 |
| Q1 2027 | 8 | $1.23 | $1.31 | $1.28 |
| Q2 2027 | 6 | $1.40 | $1.48 | $1.46 |
| Q3 2027 | 6 | $1.52 | $1.61 | $1.58 |
| Q4 2027 | 12 | $1.68 | $1.78 | $1.75 |
| Q1 2028 | 13 | $1.39 | $1.48 | $1.45 |
| Q2 2028 | 7 | $1.55 | $1.65 | $1.62 |
| Q3 2028 | 11 | $1.67 | $1.77 | $1.74 |
| Q4 2028 | 7 | $1.85 | $1.96 | $1.92 |
Abbott Laboratories Earnings Date And Information
Abbott Laboratories last posted its earnings results on Thursday, July 16th, 2026. The company reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $1.28 by $0.03. The company had revenue of 12.59 B for the quarter and had revenue of 44.33 B for the year. Abbott Laboratories has generated $4 earnings per share over the last year ($3.72 diluted earnings per share) and currently has a price-to-earnings ratio of 37.5. Abbott Laboratories has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Abbott Laboratories Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 07/28/2026 | Q2 2026 | N/A | $0.53 | N/A | $12.52 B | $12.59 B |
| 04/29/2026 | Q1 2026 | N/A | $0.62 | N/A | $11.00 B | $11.16 B |
| 02/20/2026 | Q4 2025 | N/A | $1.02 | N/A | $11.80 B | $11.46 B |
| 10/29/2025 | Q3 2025 | N/A | $0.94 | N/A | $11.39 B | $11.37 B |
| 07/30/2025 | Q2 2025 | N/A | $1.02 | N/A | $11.09 B | $11.14 B |
| 04/30/2025 | Q1 2025 | N/A | $0.76 | N/A | $10.41 B | $10.36 B |
| 02/21/2025 | Q4 2024 | N/A | $5.33 | N/A | $11.03 B | $10.97 B |
| 10/31/2024 | Q3 2024 | N/A | $0.95 | N/A | $10.55 B | $10.64 B |
| 07/31/2024 | Q2 2024 | N/A | $0.75 | N/A | $10.37 B | $10.38 B |
| 05/02/2024 | Q1 2024 | N/A | $0.71 | N/A | $9.88 B | $9.96 B |
| 02/16/2024 | Q4 2023 | N/A | $0.92 | N/A | $10.19 B | $10.24 B |
| 11/01/2023 | Q3 2023 | N/A | $0.83 | N/A | $9.84 B | $10.14 B |
| 08/03/2023 | Q2 2023 | N/A | $0.79 | N/A | $9.71 B | $9.98 B |
| 05/04/2023 | Q1 2023 | N/A | $0.76 | N/A | $9.67 B | $9.75 B |
| 02/17/2023 | Q4 2022 | N/A | $0.59 | N/A | $9.66 B | $10.09 B |
| 11/01/2022 | Q3 2022 | N/A | $0.82 | N/A | $9.65 B | $10.41 B |
| 08/02/2022 | Q2 2022 | N/A | $1.15 | N/A | $10.33 B | $11.26 B |
| 05/03/2022 | Q1 2022 | N/A | $1.40 | N/A | $11.00 B | $11.90 B |
| 02/18/2022 | Q4 2021 | N/A | $1.13 | N/A | $10.71 B | $11.47 B |
| 11/03/2021 | Q3 2021 | N/A | $1.19 | N/A | $9.56 B | $10.93 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Abbott Laboratories Earnings: FAQ's
In the previous quarter, Abbott Laboratories (:ABT) reported $1.31 earnings per share (EPS) to beat the analysts' consensus estimate of $1.28 by $0.03.
The conference call for Abbott Laboratories's latest earnings report can be listened to online.
The conference call transcript for Abbott Laboratories's latest earnings report can be read online.
Abbott Laboratories (:ABT) has a recorded annual revenue of $44.33 B.
Abbott Laboratories (:ABT) has a recorded net income of $6.52 B.Abbott Laboratories has generated $3.74 earnings per share over the last four quarters.
Abbott Laboratories (:ABT) has a price-to-earnings ratio of 37.5 and price/earnings-to-growth ratio is -0.61.